Delivery Order SPE2DB25D3201-SPE2DB25FNWRD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,763.91 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the place of performance in Conshohocken, PA. This delivery order represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $49,209.51 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 9, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $82,826.37 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $33,849.19 delivery order for Wezlana 90 mg/ml syringes, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,735.28 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes. This firm fixed-price delivery order, issued on August 5, 2025, represents a non-competitive award executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6,...
- The Defense Logistics Agency awarded a $16,577.11 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Wezlana 90 mg/mL syringes. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 14, 2025, and represents a child delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award....
- The Defense Logistics Agency awarded a $17,994.08 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes, with an ultimate completion date of July 29, 2025. This competitive award, issued on July 28, 2025, carries no set-aside designation and is structured as a firm fixed-price delivery order to be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $18,464.61 to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes, with an ultimate completion date of August 26, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $15,801.47 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,540.76 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWRDDelivery Order
The Defense Logistics Agency awarded a $128,545.42 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with performance in Conshohocken, Pennsylvania and an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and utilizes AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 master agreement that extends through December 2026. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Pennsylvania, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through comprehensive pharmaceutical supply capabilities. This delivery order exemplifies DLA's ongoing pharmaceutical sourcing through its Troop Support Medical vehicle, which provides military and veteran healthcare systems with a broad spectrum of medications and medical supplies including specialty pharmaceuticals, vaccines, and medical devices. AmerisourceBergen's extensive federal contract portfolio demonstrates its competitive capability to fulfill diverse federal medical procurement requirements, with this particular order contributing to the agency's medical supply chain operations that support military readiness and healthcare delivery across the defense enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $128.5k | 9/18/25 |